Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
M De Carvalho, M Swash - Archives of neurology, 2006 - jamanetwork.com
Background The marked variability in progression of amyotrophic lateral sclerosis (ALS)
requires large numbers of patients to detect a significant effect in current clinical trial …
requires large numbers of patients to detect a significant effect in current clinical trial …
Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
M de Carvalho, M Swash - Archives of Neurology, 2006 - europepmc.org
Background The marked variability in progression of amyotrophic lateral sclerosis (ALS)
requires large numbers of patients to detect a significant effect in current clinical trial …
requires large numbers of patients to detect a significant effect in current clinical trial …
[引用][C] Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
M DE CARVALHO, M SWASH - Archives of neurology …, 2006 - pascal-francis.inist.fr
Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral
sclerosis? CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
sclerosis? CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
M de Carvalho, M Swash - Archives of neurology, 2006 - pubmed.ncbi.nlm.nih.gov
Background The marked variability in progression of amyotrophic lateral sclerosis (ALS)
requires large numbers of patients to detect a significant effect in current clinical trial …
requires large numbers of patients to detect a significant effect in current clinical trial …
[PDF][PDF] Can Selection of Rapidly Progressing Patients Shorten Clinical Trials in Amyotrophic Lateral Sclerosis?
MD Mamede de Carvalho, M Swash - Arch Neurol, 2006 - scholar.archive.org
Background: The marked variability in progression of amyotrophic lateral sclerosis (ALS)
requires large numbers of patients to detect a significant effect in current clinical trial …
requires large numbers of patients to detect a significant effect in current clinical trial …
[PDF][PDF] Can Selection of Rapidly Progressing Patients Shorten Clinical Trials in Amyotrophic Lateral Sclerosis?
MD Mamede de Carvalho, M Swash - Arch Neurol, 2006 - academia.edu
Background: The marked variability in progression of amyotrophic lateral sclerosis (ALS)
requires large numbers of patients to detect a significant effect in current clinical trial …
requires large numbers of patients to detect a significant effect in current clinical trial …
[PDF][PDF] Can Selection of Rapidly Progressing Patients Shorten Clinical Trials in Amyotrophic Lateral Sclerosis?
MD Mamede de Carvalho, M Swash - Arch Neurol, 2006 - academia.edu
Background: The marked variability in progression of amyotrophic lateral sclerosis (ALS)
requires large numbers of patients to detect a significant effect in current clinical trial …
requires large numbers of patients to detect a significant effect in current clinical trial …
[PDF][PDF] Can Selection of Rapidly Progressing Patients Shorten Clinical Trials in Amyotrophic Lateral Sclerosis?
MD Mamede de Carvalho, M Swash - Arch Neurol, 2006 - scholar.archive.org
Background: The marked variability in progression of amyotrophic lateral sclerosis (ALS)
requires large numbers of patients to detect a significant effect in current clinical trial …
requires large numbers of patients to detect a significant effect in current clinical trial …